WASHINGTON, Feb. 11 (UPI) -- The U.S. Food and Drug Administration announced the Baxter Healthcare Corp. has temporarily stopped manufacturing multiple-dose vials of injectable heparin.

WASHINGTON, Feb. 6 (UPI) -- The U.S. Food and Drug Administration said it will take action against companies marketing unapproved injectable colchicine, a drug used to treat gout.

WASHINGTON, Jan. 21 (UPI) -- The U.S. Food and Drug Administration has approved a warning for the Ortho Evra Contraceptive Transdermal Patch label concerning the risk of blood clots.

WASHINGTON, Jan. 3 (UPI) -- The U.S. Food and Drug Administration said it is reviewing new data that provide further evidence of the risks of anemia drugs on tumor growth.

WASHINGTON, Dec. 12 (UPI) -- The U.S. manufacturers of drugs containing carbamazepine have agreed to warn Asian patients to get a genetic blood test before using the medication.

WASHINGTON, Nov. 2 (UPI) -- The U.S. Food and Drug Administration says consumers should stop using two unapproved drug products advertised as treatments for erectile disfunction.

WASHINGTON, Oct. 30 (UPI) -- The U.S. Food and Drug Administration has approved Tasigna (nilotinib) capsules for treatment of Philadelphia chromosome positive chronic myeloid leukemia.

WASHINGTON, Oct. 18 (UPI) -- The U.S. Food and Drug Administration announced approval Thursday of doripenem (Doribax) injections for the treatment of complex urinary tract infections.

WASHINGTON, Oct. 16 (UPI) -- The U.S. Food and Drug Administration announced approval Tuesday of raltegravir tablets for treatment of the human immunodeficiency virus.